Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of $12.10 billion. The enterprise value is $12.61 billion.
Important Dates
The last earnings date was Thursday, February 19, 2026, after market close.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Guardant Health has 131.17 million shares outstanding. The number of shares has increased by 2.14% in one year.
| Current Share Class | 131.17M |
| Shares Outstanding | 131.17M |
| Shares Change (YoY) | +2.14% |
| Shares Change (QoQ) | +3.08% |
| Owned by Insiders (%) | 3.68% |
| Owned by Institutions (%) | 100.08% |
| Float | 126.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.32 |
| Forward PS | 9.45 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.84
| Current Ratio | 4.84 |
| Quick Ratio | 4.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -111.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -15.59% |
| Return on Invested Capital (ROIC) | -19.43% |
| Return on Capital Employed (ROCE) | -25.50% |
| Weighted Average Cost of Capital (WACC) | 11.70% |
| Revenue Per Employee | $391,868 |
| Profits Per Employee | -$166,112 |
| Employee Count | 2,506 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 4.45 |
Taxes
| Income Tax | -1.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +116.76% in the last 52 weeks. The beta is 1.65, so Guardant Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | +116.76% |
| 50-Day Moving Average | 105.58 |
| 200-Day Moving Average | 74.64 |
| Relative Strength Index (RSI) | 34.73 |
| Average Volume (20 Days) | 2,236,269 |
Short Selling Information
The latest short interest is 10.52 million, so 8.02% of the outstanding shares have been sold short.
| Short Interest | 10.52M |
| Short Previous Month | 9.48M |
| Short % of Shares Out | 8.02% |
| Short % of Float | 8.32% |
| Short Ratio (days to cover) | 5.39 |
Income Statement
In the last 12 months, Guardant Health had revenue of $982.02 million and -$416.28 million in losses. Loss per share was -$3.32.
| Revenue | 982.02M |
| Gross Profit | 633.01M |
| Operating Income | -436.30M |
| Pretax Income | -417.54M |
| Net Income | -416.28M |
| EBITDA | -396.56M |
| EBIT | -436.30M |
| Loss Per Share | -$3.32 |
Full Income StatementBalance Sheet
The company has $1.20 billion in cash and $1.71 billion in debt, with a net cash position of -$508.54 million or -$3.88 per share.
| Cash & Cash Equivalents | 1.20B |
| Total Debt | 1.71B |
| Net Cash | -508.54M |
| Net Cash Per Share | -$3.88 |
| Equity (Book Value) | -99.31M |
| Book Value Per Share | -0.76 |
| Working Capital | 1.16B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$184.76 million and capital expenditures -$48.31 million, giving a free cash flow of -$233.07 million.
| Operating Cash Flow | -184.76M |
| Capital Expenditures | -48.31M |
| Free Cash Flow | -233.07M |
| FCF Per Share | -$1.78 |
Full Cash Flow StatementMargins
Gross margin is 64.46%, with operating and profit margins of -44.43% and -42.39%.
| Gross Margin | 64.46% |
| Operating Margin | -44.43% |
| Pretax Margin | -42.52% |
| Profit Margin | -42.39% |
| EBITDA Margin | -40.38% |
| EBIT Margin | -44.43% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.14% |
| Shareholder Yield | -2.14% |
| Earnings Yield | -3.44% |
| FCF Yield | -1.93% |
Dividend DetailsAnalyst Forecast
The average price target for Guardant Health is $117.80, which is 27.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $117.80 |
| Price Target Difference | 27.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 26.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guardant Health has an Altman Z-Score of 0.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.46 |
| Piotroski F-Score | 4 |
